Literature DB >> 9155075

Measurement of the peripheral dose for the tangential breast treatment technique with Co-60 gamma radiation and high energy X-rays.

P H Van der Giessen1.   

Abstract

BACKGROUND AND
PURPOSE: Published data to estimate the dose outside the primary beam, i.e. the peripheral dose (PD), are only valid for perpendicularly incident beams. In radiotherapy of breast cancer patients often a tangential beam technique is used, for which the published PD data cannot be applied.
MATERIAL AND METHODS: Measurements were made in a water phantom for three sizes of a breast phantom, representing a small, medium, and large breast. Open and wedged beams were used. Photon energies were 60Co gamma radiation and 6- to 25-MV X-rays. The PD was also determined in a humanoid phantom. To check the validity of the phantom measurements, the PD was measured in 50 patients referred to this institute for radiotherapy of the breast.
RESULTS: The mean of the ratios of the measured to the estimated PD was 1.12, with a standard deviation of 26%. The data set was used to estimate the fetal dose for a 'standard' patient, as a function of stage of pregnancy.
CONCLUSIONS: The measurements have resulted in a data set, which enables calculation of the peripheral dose for the tangential beam technique. The accuracy is considered to be adequate for risk assessment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155075     DOI: 10.1016/s0167-8140(96)01884-1

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

1.  Estimation of peripheral dose from Co60 beam in water phantom measured in Secondary Standard Dosimetry Laboratory, Pakistan.

Authors:  Muhammad Shahban; Babar Hussain; Khalid Mehmood; Shakeel Ur Rehman
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-21

2.  Peripheral dose measurement in high-energy photon radiotherapy with the implementation of MOSFET.

Authors:  Vassiliki Vlachopoulou; Georgia Malatara; Harry Delis; Kiki Theodorou; Dimitrios Kardamakis; George Panayiotakis
Journal:  World J Radiol       Date:  2010-11-28

Review 3.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.

Authors:  X George Xu; Bryan Bednarz; Harald Paganetti
Journal:  Phys Med Biol       Date:  2008-06-09       Impact factor: 3.609

4.  Immediate reconstruction with an expander/implant following ablatio mammae because of breast cancer : side effects and cosmetic results after adjuvant chest wall radiotherapy.

Authors:  Marc D Piroth; Daniela M Piroth; Michael Pinkawa; Seth G Woodruff; Richard Holy; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

5.  Cancer in pregnancy.

Authors:  Gurpreet Singh
Journal:  Indian J Surg       Date:  2010-01-13       Impact factor: 0.656

6.  Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapy.

Authors:  Michael L Taylor; Tomas Kron
Journal:  J Med Phys       Date:  2011-04

Review 7.  Breast cancer in pregnancy: a literature review.

Authors:  S Deckers; F Amant
Journal:  Facts Views Vis Obgyn       Date:  2009

Review 8.  Locoregional treatment of breast cancer during pregnancy.

Authors:  Antonio Toesca; Oreste Gentilini; Fedro Peccatori; Hatem A Azim; Frederic Amant
Journal:  Gynecol Surg       Date:  2014-09-30

9.  Electron Beam Intraoperative Radiotherapy (ELIOT) in Pregnant Women with Breast Cancer: From in Vivo Dosimetry to Clinical Practice.

Authors:  Maria Leonardi; Agnese Cecconi; Rosa Luraschi; Elena Rondi; Federica Cattani; Roberta Lazzari; Anna Morra; Santos Soto; Vanna Zanagnolo; Viviana Galimberti; Oreste Gentilini; Fedro Peccatori; Barbara Jereczek-Fossa; Roberto Orecchia
Journal:  Breast Care (Basel)       Date:  2017-12-13       Impact factor: 2.860

10.  Calculation of organ doses from breast cancer radiotherapy: a Monte Carlo study.

Authors:  Theocharis Berris; Michael Mazonakis; John Stratakis; Antonios Tzedakis; Anastasia Fasoulaki; John Damilakis
Journal:  J Appl Clin Med Phys       Date:  2013-01-07       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.